Koyfin Home > Directory > Health Care > Abbott Laboratories > Total Debt / (EBITDA-CAPEX)

Abbott Laboratories Total Debt / (EBITDA-CAPEX) Chart (ABT)

Abbott Laboratories annual/quarterly Total Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Abbott Laboratories Total Debt / (EBITDA-CAPEX) for the quarter ending September 09, 2020 was $3m a 3.91% increase of 0m year over year
  • Abbott Laboratories Total Debt / (EBITDA-CAPEX) for the last 12 months ending September 09, 2020 was $3m a 7.96% increase of 0m year over year
  • Abbott Laboratories Annual Total Debt / (EBITDA-CAPEX) for 2019 was $3m a -16.19% decrease of 0m from 2018
  • Abbott Laboratories Annual Total Debt / (EBITDA-CAPEX) for 2018 was $3m a -71.84% decrease of -2m from 2017
  • Abbott Laboratories Annual Total Debt / (EBITDA-CAPEX) for 2017 was $6m a -10.21% decrease of -1m from 2016
Other Ratios Metrics:
  • Abbott Laboratories Total Debt / Capital for the quarter ending December 12, 2018 was $44m a 5.51% increase of 2m year over year
  • Abbott Laboratories Other Liabilities for the quarter ending September 09, 2018 was $8,407m a -7.41% decrease of -623m year over year
  • Abbott Laboratories Total Debt / Equity for the quarter ending December 12, 2018 was $77m a 9.36% increase of 7m year over year
View Chart On Koyfin

Quarterly ABT Total Debt / (EBITDA-CAPEX) Data

09/2020$3m
06/2020$5m
03/2020$3m
12/2019$3m
09/2019$3m
06/2019$3m
03/2019$4m
12/2018$3m
09/2018$4m
06/2018$4m

Annual ABT Total Debt / (EBITDA-CAPEX) Data

2019$3m
2018$3m
2017$6m
2016$6m
2015$3m
2014$2m
2013$2m
2012$8m
2011$5m
2010$2m